Furthermore, although these approaches have previously been successful in other studies, the genetic signal may have been too small to affect the outcomes, and a clinical trial of a drug that inhibits PCSK9 in patients with sepsis could reach different conclusions. This evidence concerns the gene PCSK9 and Sepsis.